West Pharma (WST) Tops Q1 EPS by 19c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus, FY20 Revenue Outlook Above Consensus
Go back to West Pharma (WST) Tops Q1 EPS by 19c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus, FY20 Revenue Outlook Above Consensus| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 361.78 -0.53 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $362.31 | 52 Week High | $84.33 | |||
| Open | $363.78 | 52 Week Low | $53.88 | |||
| Day High | $366.12 | P/E | 230.43 | |||
| Day Low | $361.05 | EPS | $1.57 | |||
| Volume | 506,796 | |||||
